文献速递小儿眼科与斜弱视白内障与屈光手术

婴儿先天性白内障术后局部糖皮质激素治疗中的肾上腺抑制

Adrenal Suppression in Infants Treated with Topical Ocular Glucocorticoids.
PubMed 文献 · Ophthalmology · 2018-06-19

肾上腺抑制者接受氢化可的松替代治疗,中位3.1个月后肾上腺功能恢复。

要点

  • 肾上腺抑制者测试前最后5天的累积每公斤体重糖皮质激素剂量显著高于测试结果正常者。
  • 肾上腺抑制者接受氢化可的松替代治疗,中位3.1个月后肾上腺功能恢复。

核心结论

  • 在接受先天性白内障术后标准局部糖皮质激素方案治疗的婴儿中,测试时三分之二出现肾上腺抑制。
  • 累积每日糖皮质激素剂量与ACTH刺激试验结果之间存在显著关联。
  • 肾上腺抑制是严重但可治疗的状况,建议对接受与本研究方案相当的局部糖皮质激素剂量的婴儿进行系统性肾上腺功能评估,并仔细评估其他治疗方案。

研究设计与样本

  • 回顾性、连续病例系列。
  • 纳入2011年1月至2015年5月在1个中心因先天性白内障接受手术的所有2岁以下儿童,共26例连续婴儿。
  • 回顾病历收集标准促肾上腺皮质激素(ACTH)刺激试验的结果与时机,以及每公斤体重糖皮质激素剂量。

主要发现

  • 26例婴儿中11例(42%)在治疗停止后中位21天(范围6-89天)接受测试,所有结果均正常。
  • 肾上腺功能受抑制的儿童在测试前最后5天接受的累积每公斤体重糖皮质激素剂量显著高于测试结果正常的儿童。
  • 肾上腺抑制的婴儿接受氢化可的松替代治疗,肾上腺功能在中位3.1个月(范围2.3个月至2.3年)后恢复。

临床怎么用

  • 对接受与本研究方案相当的局部眼用糖皮质激素剂量的婴儿,建议进行系统性肾上腺功能评估。
  • 对肾上腺抑制的婴儿使用氢化可的松替代治疗;原文报告肾上腺功能在中位3.1个月后恢复。
  • 原文建议仔细评估其他治疗方案。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To analyze the incidence of adrenal suppression and the glucocorticoid (GC) dose per kilogram body weight given in infants treated with standard protocol for topical ophthalmic GCs after congenital cataract surgery. DESIGN: Retrospective, consecutive case series. PARTICIPANTS: All children younger than 2 years of age who underwent operation for congenital cataract between January 2011 and May 2015 in 1 center. METHODS: Patient charts were reviewed to collect data on results and timing of a standard corticotropin (adrenocorticotropic hormone [ACTH]) stimulation test and GC dose per kilogram body weight. MAIN OUTCOME MEASURES: Incidence of adrenal suppression in children tested on GC treatment. Glucocorticoid dose per kilogram body weight. RESULTS: Among 26 consecutive infants, 15 (58%) were tested while they were still on GC treatment. Ten of these 15 infants (67%) had adrenal suppression, 2 of whom had obvious clinical signs of Cushing's syndrome and 1 of whom had signs of Addisonian crises during general anesthesia. Eleven of the 26 infants (42%) were tested at a median time of 21 days (range, 6-89) after treatment cessation, and they all had normal test results. Children with suppressed adrenal function had received cumulative GC doses per body weight that were significantly higher the last 5 days before testing compared with children with normal test results. Infants with adrenal suppression were treated with hydrocortisone replacement therapy. Adrenal function recovered after a median of 3.1 months (range, 2.3 months to 2.3 years). CONCLUSIONS: Two thirds of the infants tested during treatment with a standard GC protocol after congenital cataract surgery showed adrenal suppression. There was a significant association between the cumulative daily dose of GCs and the test result. Because adrenal suppression is a serious but treatable condition, we recommend a systematic assessment of adrenal function in infants treated with doses of topical ocular GCs comparable to our regimen and careful evaluations of other treatment regimens.

来源:Ophthalmology,查看原文。版权归原作者所有。

引用

  1. Bangsgaard R, Main KM, Boberg-Ans G, et al. Adrenal Suppression in Infants Treated with Topical Ocular Glucocorticoids. Ophthalmology. 2018. PMID: 29934270. doi:10.1016/j.ophtha.2018.04.035

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。